The role of nitric oxide in chemically- and electrically-induced seizures in mice

Neuroscience Letters

Volumn 217, Issue 2-3, 1996, Pages 145-148

  Przegaliñski, Edmund ^a   Baran, Leokadia ^a   Siwanowicz, Joanna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Electroconvulsive threshold; Mice; N Methyl D aspartate; Nitric oxide; Nitric oxide synthase inhibitors; Pentylenetetrazol; Pilocarpine; Seizures

Indexed keywords

7 NITROINDAZOLE; N METHYL DEXTRO ASPARTIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PENTETRAZOLE; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVULSION; ENANTIOMER; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

EID: 0030592534     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)13085-8     Document Type: Article

References (26)

1. [1] Bredt, D.S. and Snyder, S.H., Nitric oxide, a novel neuronal messenger, Neuron, 8 (1992) 3-11.
2. [2] Buisson, A., Lakhmeche, N., Verrecchia, C., Plothine, M. and Boulu, R.G., Nitric oxide: an endogenous anticonvulsant substance, NeuroReport, 4 (1993) 444-446.
3. G-Nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists, Circ. Res., 72 (1993) 387-395.
4. [4] De Sarro, G.B., Di Paola, E.D., De Sarro, A. and Vidal, M.J., Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex, Fundam. Clin. Pharmacol., 5 (1991) 503-511.
5. [5] Fewell, J.E. and Johnson, P., Acute increases in blood pressure cause arousal from sleep in lambs, Brain Res., 311 (1994) 259-265.
6. [6] Garthwaite, J., Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci., 14 (1991) 60-67.
7. [7] Garthwaite, J., Charles, S.L. and Chess-Williams, R., Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intracellular messenger in the brain, Nature, 336 (1988) 385-387.
8. [8] Haberny, K.A., Pou, S. and Eccles, C.U., Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis, Neurosci. Lett., 146 (1992) 187-190.
9. ω-nitro-L-arginine on seizures induced by several drugs in mice, Pharmacol. Biochem. Behav., 53 (1996) 673-677.
10. [10] Knowles, R.G., Palacios, M., Palmer, R.M.J. and Moncada, S., Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble quanylate cyclase, Proc. Natl. Acad. Sci. USA, 86 (1989) 5159-5162.
11. [11] Lei, S.Z., Pan, Z.-H., Aggarwal, S.K., Chen, H.-S.V., Hartman, J., Sucher, N.J. and Lipton, S.A., Effect of nitric oxide production on the redox tnodulatory site of the NMDA receptor-channel complex, Neuron, 8 (1992) 1087-1099.
12. [12] Litchfield, J.T. and Wilcoxon, F., A simplified method of evaluating dose-effect experiments, J. Pharmacol. Exp. Ther., 96 (1949) 99-103.
13. [13] Maggio, R., Fumagalli, F., Donati, E., Barbier, P., Racagni, G., Corsini, G.U. and Riva, M., Inhibition of nitric oxide synthase dramatically potentiates seizures induced by kainic acid and pilocarpine in rats, Brain Res., 679 (1995) 184-187.
14. [14] Manzoni, O., Prezeau, L., Marin, P., Deshager, S., Bockaert, J. and Fagni, L., Nitric oxide-induced blockade of NMDA receptors, Neuron, 8 (1992) 653-662.
15. [15] Meldrum, B., Amino acid neurotransmitters and new approaches to anticonvulsant drug action, Epilepsia, 25 (1984) S140-S149.
16. [16] Moncada, S., Palmer, R.M.J. and Higgs, S.A., Nitric oxide: physiology, pathophysiology and pharmacology, Pharmacol. Rev., 43 (1991) 109-142.
17. [17] Moore, P.K., Babbedge, R.C., Wallace, P., Gaffen, Z.A. and Hart, S.L., 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure, Br. J. Pharmacol., 108 (1993) 296-297.
18. [18] Moore, P.K., Wallace, P., Gaffen, Z., Hart, S.L. and Babbedge, R.C., Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects, Br. J. Pharmacol., 110 (1993) 219-224.
19. [19] Mülsch, A., Busse, R., Mordvintcev, P.I., Vanin, A.F., Nielsen, E.O., Scheel-Kruger, J. and Olesen, S.-P., Nitric oxide promotes seizure activity in kainate-treated rats, NeuroReport, 5 (1994) 2325-2328.
20. [20] Osonoe, K., Mori, N., Suzuki, K. and Osonoe, M., Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats, Brain Res., 663 (1994) 338-340.
21. [21] Przegalinski, E., Baran, L. and Siwanowicz, J., The role of nitric oxide in the kainate-induced seizures in mice, Neurosci. Lett., 170 (1994) 74-76.
22. [22] Rondouin, G., Bockaert, J. and Lerner-Natoli, M., L-Nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats, NeuroReport, 4 (1993) 1187-1190.
23. [23] Salter, M., Duffy, C. and Hazelwood, R., Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results, Neuropharmacology, 34 (1995) 327-334.
24. [24] Schuman, E.M. and Madison, D.V., Nitric oxide and synaptic function, Annu. Rev. Neurosci., 17 (1994) 153-183.
25. [25] Van Leeuven, R., De Vries, R. and Dzoljic, M.R., 7-Nitro indazole, an inhibitor of neuronal nitric oxide synthase, attenuates pilocarpine-induced seizures, Eur. J. Pharmacol., 287 (1995) 211-213.
26. [26] Wood, P.L., Pharmacology of the second messenger, cyclic quanosine 3′, 5′-monophosphate, in the cerebellum, Pharmacol. Rev., 43 (1991) 1-25.